Neoleukin Therapeutics Inc Stock News

With its recently acquired Ashburton gold project in Western Australia now gaining greater focus and 10 priority targets in Victoria, Kalamazoo Resources (ASX: KZR) has granted Canada-listed Novo Reso

Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has been granted an option and an additional earn-in

The intertwined companies made healthy gains at the end of the week, though the reason for them wasn't immediately evident.

Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has signed a binding terms sheet (the “Terms Sheet”)

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 21 September 2020 – On 6 August 2020, Novo Nordisk initiated a share repurchase programme...

Fmr LLC lessened its holdings in Novo Nordisk A/S (NYSE:NVO) by 24.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund own

The

LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs

Dicerna develops RNAi therapies. Several large-cap pharma companies are collaborators.

Novo Nordisk A/S, the Danish drugmaker, is exploring whether a new class of medicines that helps people lose weight and control diabetes also has potential in fighting COVID-19.